What is Leidos Holdings, Inc.'s earnings per share (EPS)?

Leidos Holdings, Inc. (LDOS) reported diluted earnings per share of $11.14 for fiscal year 2025. This represents a 20.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Leidos Holdings, Inc. (LDOS) Financials

LDOS

Trailing 12 months to July 3, 2026

Revenue $17.6B +3.4% YoY

Net Income $1.4B -1.9% YoY

EPS (Diluted) $10.71 +1.5% YoY

Free Cash Flow $2.2B +63.2% YoY

Market Cap $16.2B as of Sep 11, 2026

Price / Sales 0.9x on $17.6B revenue, trailing 12 months to July 3, 2026

Price / Earnings 11.8x on $1.4B net income, trailing 12 months to July 3, 2026

Price / Book 3.1x on $5.3B equity, Q2 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended Jul 3, 2026 Reported Aug 4, 2026 Currency USD FYE January

Newest figures come from the 10-Q for Q2 FY2027, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LDOS SEC filings page.

Leidos Holdings, Inc. (LDOS) reported $17.6B in revenue over the twelve months to Jul 3, 2026, up 3.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LDOS FY2025 2026-09-05

Leidos' margin expansion is turning moderate revenue growth into faster cash generation while leverage remains broadly contained.

Profit recovery was cash-backed: operating cash flow rose from $1.19B in FY2023 to $1.75B in FY2025, while free cash flow also increased, indicating the rebound was not confined to accounting earnings. Operating margin nearly tripled from 4.0% to 12.3% as gross margin expanded, pointing to better economics below the gross-profit line as well as a larger gross-profit pool.

Revenue increased from $15.4B in FY2023 to $17.2B in FY2025, but operating income grew much faster, suggesting fixed or semi-fixed costs were absorbed more efficiently rather than the improvement coming from volume alone.

The balance sheet moved from current liabilities exceeding current assets in FY2022 to a 1.7x current ratio in FY2025, while debt-to-equity stayed near 0.9x; working-capital flexibility improved without a comparable rise in leverage. 2025 capital spending was $125M against free cash flow of $1.63B, indicating a business that requires relatively modest reinvestment to support its reported cash generation.

Financial Health Signals

Financial Health Score 58/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Leidos Holdings, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Leidos Holdings, Inc. has an operating margin of 12.3%, meaning the company retains $12 of operating profit per $100 of revenue. This strong profitability earns a score of 67/100, reflecting efficient cost management and pricing power. This is up from 11.0% the prior year.

Growth

Leidos Holdings, Inc.'s revenue grew a modest 3.1% year-over-year to $17.2B. This slow but positive growth earns a score of 52/100.

Leverage

Leidos Holdings, Inc. has a moderate D/E ratio of 0.94. This balance of debt and equity financing earns a leverage score of 38/100.

Liquidity

Leidos Holdings, Inc.'s current ratio of 1.70 indicates adequate short-term liquidity, earning a score of 50/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Leidos Holdings, Inc. has a free cash flow margin of 9.5%, earning a moderate score of 60/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Leidos Holdings, Inc. earns a strong 29.4% return on equity (ROE), meaning it generates $29 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 78/100. This is up from 28.4% the prior year.

Altman Z-Score Safe

3.58

Leidos Holdings, Inc. scores 3.58, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

Leidos Holdings, Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.21x

For every $1 of reported earnings, Leidos Holdings, Inc. generates $1.21 in operating cash flow ($1.8B OCF vs $1.4B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

10.39x

Leidos Holdings, Inc. earns $10.39 in operating income for every $1 of interest expense ($2.1B vs $203.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.6B

YoY+7.2%

QoQ+3.6%

5Y CAGR+5.7%

10Y CAGR+13.5%

Leidos Holdings, Inc. generated $4.6B in revenue in Q2 2027. This represents an increase of 7.2% from the same quarter a year earlier. Against the prior quarter it is up 3.6%.

EBITDA

$595.0M

YoY-7.5%

QoQ+2.6%

5Y CAGR+11.3%

10Y CAGR+21.6%

Leidos Holdings, Inc.'s EBITDA was $595.0M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 7.5% from the same quarter a year earlier. Against the prior quarter it is up 2.6%.

Net Income

$354.0M

YoY-9.5%

QoQ+7.9%

5Y CAGR+15.9%

10Y CAGR+24.1%

Leidos Holdings, Inc. reported $354.0M in net income in Q2 2027. This represents a decrease of 9.5% from the same quarter a year earlier. Against the prior quarter it is up 7.9%.

EPS (Diluted)

$2.81

YoY-6.6%

QoQ+9.8%

5Y CAGR+19.0%

10Y CAGR+17.7%

Leidos Holdings, Inc. earned $2.81 per diluted share (EPS) in Q2 2027. This represents a decrease of 6.6% from the same quarter a year earlier. Against the prior quarter it is up 9.8%.

Cash & Balance Sheet

Free Cash Flow

$761.0M

YoY+66.5%

QoQ+181.9%

10Y CAGR+27.1%

Leidos Holdings, Inc. generated $761.0M in free cash flow in Q2 2027, representing cash available after capex. This represents an increase of 66.5% from the same quarter a year earlier. Against the prior quarter it is up 181.9%.

Cash & Debt

$748.0M

YoY-19.6%

QoQ+63.7%

5Y CAGR+17.2%

10Y CAGR+1.1%

Leidos Holdings, Inc. held $748.0M in cash against $6.0B in long-term debt as of Q2 2027.

Dividends Per Share

$0.43

YoY+7.5%

QoQ0.0%

Leidos Holdings, Inc. paid $0.43 per share in dividends in Q2 2027. This represents an increase of 7.5% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

125M

YoY-2.2%

QoQ-0.2%

5Y CAGR-2.4%

10Y CAGR+5.6%

Leidos Holdings, Inc. had 125M shares outstanding in Q2 2027. This represents a decrease of 2.2% from the same quarter a year earlier. Against the prior quarter it is down 0.2%.

Margins & Returns

Gross Margin

17.9%

YoY-0.5pp

QoQ+0.6pp

5Y change+3.5pp

Leidos Holdings, Inc.'s gross margin was 17.9% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.

Operating Margin

11.3%

YoY-2.2pp

QoQ-0.3pp

5Y change+3.5pp

10Y change+5.5pp

Leidos Holdings, Inc.'s operating margin was 11.3% in Q2 2027, reflecting core business profitability. This is down 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.3 percentage points.

Net Margin

7.8%

YoY-1.4pp

QoQ+0.3pp

5Y change+2.9pp

10Y change+4.6pp

Leidos Holdings, Inc.'s net profit margin was 7.8% in Q2 2027, showing the share of revenue converted to profit. This is down 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Return on Equity

6.7%

YoY-1.7pp

QoQ+0.2pp

5Y change+2.6pp

10Y change+3.1pp

Leidos Holdings, Inc.'s ROE was 6.7% in Q2 2027, measuring profit generated per dollar of shareholder equity. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Capital Allocation

Share Buybacks

$66.0M

QoQ-67.0%

10Y CAGR+20.8%

Leidos Holdings, Inc. spent $66.0M on share buybacks in Q2 2027, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 67.0%.

Capital Expenditures

$32.0M

YoY+10.3%

QoQ+3.2%

5Y CAGR+8.8%

10Y CAGR+26.7%

Leidos Holdings, Inc. invested $32.0M in capex in Q2 2027, funding long-term assets and infrastructure. This represents an increase of 10.3% from the same quarter a year earlier. Against the prior quarter it is up 3.2%.

R&D Spending

Not reported for Q2 2027.

LDOS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LDOS quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$17.6B	$17.2B+3.1%	$16.7B+7.9%	$15.4B+7.2%	$14.4B+4.8%	$13.7B+11.7%	$12.3B+10.8%	$11.1B+8.8%	$10.2B+0.2%	$10.2B+44.4%	$7.0B+49.5%	$4.7B-6.9%	$5.1B-12.0%	$5.8B-10.8%	$6.4B+10.5%	$5.8B
Cost of Revenue	$14.5B	$14.1B+1.5%	$13.9B+5.1%	$13.2B+7.2%	$12.3B+5.0%	$11.7B+11.0%	$10.6B+10.6%	$9.5B+9.9%	$8.7B-0.5%	$8.7B+43.2%	$6.1B+47.2%	$4.1B-5.6%	$4.4B-12.0%	$5.0B-10.0%	$5.5B+3.7%	$5.4B
Gross Profit	$3.1B	$3.1B+10.8%	$2.8B+24.7%	$2.2B+7.7%	$2.1B+3.5%	$2.0B+15.9%	$1.7B+12.2%	$1.5B+2.9%	$1.5B+5.0%	$1.4B+52.3%	$940.0M+66.1%	$566.0M-15.6%	$671.0M-12.1%	$763.0M-15.3%	$901.0M+85.8%	$485.0M
R&D Expenses	N/A	$187.0M+24.7%	$150.0M+17.2%	$128.0M+10.3%	$116.0M+6.4%	$109.0M+49.3%	$73.0M+49.0%	$49.0M+6.5%	$46.0M+9.5%	$42.0M-4.5%	$44.0M+51.7%	$29.0M-21.6%	$37.0M-17.8%	$45.0M-4.3%	$47.0M-36.5%	$74.0M
SG&A Expenses	$1.1B	$999.0M+1.6%	$983.0M+4.4%	$942.0M-0.9%	$951.0M+11.8%	$851.0M+10.5%	$770.0M+11.8%	$689.0M-5.5%	$729.0M-1.1%	$737.0M+74.6%	$422.0M+110.0%	$201.0M-28.2%	$280.0M-36.4%	$440.0M-5.8%	$467.0M	N/A
Operating Income	$2.0B	$2.1B+15.4%	$1.8B+194.2%	$621.0M-42.9%	$1.1B-5.6%	$1.2B+15.4%	$998.0M+9.4%	$912.0M+21.8%	$749.0M+34.0%	$559.0M+34.1%	$417.0M+30.3%	$320.0M+249.5%	-$214.0M-231.3%	$163.0M-61.3%	$421.0M+825.9%	-$58.0M
EBITDA	N/A	$2.4B+13.3%	$2.1B+122.4%	$952.0M-33.0%	$1.4B-3.8%	$1.5B+15.4%	$1.3B+11.7%	$1.1B+13.9%	$1.0B+12.4%	$895.0M+66.0%	$539.0M+49.3%	$361.0M+337.5%	-$152.0M-162.6%	$243.0M-52.4%	$511.0M+1603.3%	$30.0M
Interest Expense	$223.0M	$203.0M+5.2%	$193.0M-9.0%	$212.0M+6.5%	$199.0M+7.6%	$185.0M+1.6%	$182.0M+23.8%	$147.0M+1.4%	$145.0M-2.0%	$148.0M+54.2%	$96.0M+81.1%	$53.0M-29.3%	$75.0M-8.5%	$82.0M-11.8%	$93.0M-18.4%	$114.0M
Income Tax	$398.0M	$447.0M+15.2%	$388.0M+99.0%	$195.0M+1.0%	$193.0M-7.2%	$208.0M+36.8%	$152.0M-22.4%	$196.0M+600.0%	$28.0M-3.4%	$29.0M-59.7%	$72.0M-35.7%	$112.0M+138.3%	$47.0M+1075.0%	$4.0M-81.8%	$22.0M-69.9%	$73.0M
Net Income	$1.4B	$1.4B+15.5%	$1.3B+530.2%	$199.0M-70.9%	$685.0M-9.0%	$753.0M+19.9%	$628.0M-5.8%	$667.0M+14.8%	$581.0M+58.7%	$366.0M+50.0%	$244.0M+0.8%	$242.0M+172.5%	-$334.0M-303.7%	$164.0M-68.8%	$525.0M+789.8%	$59.0M
EPS (Basic)	N/A	$11.31+20.8%	$9.36+545.5%	$1.45-71.0%	$5.00-6.4%	$5.34+20.8%	$4.42-5.2%	$4.66+21.0%	$3.85+59.8%	$2.41+0.8%	$2.39-28.0%	$3.32+173.6%	-$4.51-332.5%	$1.94-68.7%	$6.19+810.3%	$0.68
EPS (Diluted)	$10.71	$11.14+20.8%	$9.22+540.3%	$1.44-71.0%	$4.96-5.9%	$5.27+20.9%	$4.36-5.2%	$4.60+21.1%	$3.80+59.7%	$2.38+1.3%	$2.35	$3.27+175.0%	-$4.36-324.7%	$1.94	$6.19+810.3%	$0.68
Diluted Shares (Avg)	N/A	130M-4.4%	136M-1.4%	138M0.0%	138M-3.5%	143M-0.7%	144M-0.7%	145M-5.2%	153M-0.6%	154M+48.1%	104M	74M0.0%	74M-10.8%	83M	83M-1.2%	84M

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Revenue	$4.6B+7.2%	$4.4B+3.7%	$4.2B-3.6%	$4.5B+6.7%	$4.3B+2.9%	$4.2B+6.8%	$4.4B+9.7%	$4.2B+6.9%
Cost of Revenue	$3.7B+7.8%	$3.6B+4.3%	$3.5B-5.6%	$3.6B+6.4%	$3.5B+1.3%	$3.5B+4.5%	$3.7B+8.5%	$3.4B+2.8%
Gross Profit	$817.0M+4.5%	$761.0M+0.5%	$739.0M+6.6%	$821.0M+7.7%	$782.0M+10.9%	$757.0M+18.7%	$693.0M+16.5%	$762.0M+29.8%
SG&A Expenses	$283.0M+30.4%	$223.0M-3.0%	$266.0M-4.7%	$286.0M+15.8%	$217.0M-6.1%	$230.0M+1.8%	$279.0M+19.7%	$247.0M+3.3%
Operating Income	$514.0M-10.0%	$508.0M-4.2%	$473.0M+12.4%	$535.0M+3.7%	$571.0M+20.2%	$530.0M+27.7%	$421.0M+16.6%	$516.0M+253.6%
EBITDA	$595.0M-7.5%	$580.0M-3.2%	$548.0M+9.6%	$609.0M+3.7%	$643.0M+17.8%	$599.0M+23.8%	$500.0M+12.6%	$587.0M+331.1%
Interest Expense	$69.0M+25.5%	$55.0M+12.2%	$48.0M+2.1%	$51.0M+10.9%	$55.0M+7.8%	$49.0M0.0%	$47.0M+195.9%	$46.0M-13.2%
Income Tax	$95.0M-24.0%	$94.0M-16.8%	$94.0M+1.1%	$115.0M+6.5%	$125.0M+22.5%	$113.0M+32.9%	$93.0M+16.3%	$108.0M+1250.0%
Net Income	$354.0M-9.5%	$328.0M-9.6%	$327.0M+15.1%	$367.0M+0.8%	$391.0M+21.4%	$363.0M+27.8%	$284.0M+24.0%	$364.0M+191.2%
EPS (Basic)	$2.81-7.3%	$2.60-6.8%	$2.62+20.7%	$2.87+5.5%	$3.03+26.8%	$2.79+33.5%	$2.17+29.9%	$2.72+193.5%
EPS (Diluted)	$2.81-6.6%	$2.56-7.6%	$2.52+20.6%	$2.82+5.2%	$3.01+27.0%	$2.77+33.8%	$2.09+25.9%	$2.68+192.1%
Diluted Shares (Avg)	126M-3.1%	128M-2.3%	N/A	130M-4.4%	130M-4.4%	131M-4.4%	N/A	136M-0.7%

Not reported in any period shown, so not listed: R&D Expenses.

LDOS Balance Sheet

LDOS quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$13.5B+3.7%	$13.0B+2.5%	$12.7B-2.9%	$13.1B-1.4%	$13.3B+6.0%	$12.5B+33.6%	$9.4B+6.8%	$8.8B-2.4%	$9.0B-1.6%	$9.1B+171.0%	$3.4B+2.7%	$3.3B-21.2%	$4.2B-29.2%	$5.9B-11.9%	$6.7B
Current Assets	$4.8B+11.1%	$4.3B+8.2%	$4.0B+9.9%	$3.6B+0.7%	$3.6B+8.4%	$3.3B+18.7%	$2.8B-1.0%	$2.8B+6.2%	$2.7B+12.3%	$2.4B+32.8%	$1.8B+10.8%	$1.6B-10.5%	$1.8B-50.0%	$3.6B-14.5%	$4.2B
Cash & Equivalents	$1.1B+30.5%	$849.0M+32.4%	$641.0M+24.2%	$516.0M-29.0%	$727.0M+38.7%	$524.0M-21.6%	$668.0M+104.3%	$327.0M-16.2%	$390.0M+3.7%	$376.0M-42.7%	$656.0M+42.9%	$459.0M+6.7%	$430.0M-41.5%	$735.0M-53.8%	$1.6B
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$342.0M+8.6%	$315.0M+1.6%	$310.0M+8.0%	$287.0M+4.7%	$274.0M-0.7%	$276.0M+283.3%	$72.0M	N/A	$76.0M+13.4%	$67.0M-4.3%	$70.0M0.0%	$70.0M+18.6%	$59.0M-25.3%	$79.0M-53.0%	$168.0M
Accounts Receivable	$2.7B+2.4%	$2.6B+8.9%	$2.4B+3.4%	$2.4B+7.4%	$2.2B+2.4%	$2.1B+23.2%	$1.7B-7.6%	$1.9B+2.5%	$1.8B+10.5%	$1.7B+79.9%	$921.0M+2.8%	$896.0M-17.2%	$1.1B	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$6.3B+4.2%	$6.1B-0.5%	$6.1B-8.7%	$6.7B-0.7%	$6.7B+6.8%	$6.3B+28.5%	$4.9B+1.1%	$4.9B-2.3%	$5.0B+7.6%	$4.6B+282.9%	$1.2B0.0%	$1.2B-28.7%	$1.7B0.0%	$1.7B+29.3%	$1.3B
Total Liabilities	$8.5B-0.2%	$8.6B+1.3%	$8.4B-3.2%	$8.7B-2.2%	$8.9B+3.2%	$8.6B+45.1%	$6.0B+9.0%	$5.5B-2.8%	$5.6B-6.3%	$6.0B+160.5%	$2.3B+0.8%	$2.3B-11.1%	$2.6B-21.2%	$3.3B-27.4%	$4.5B
Current Liabilities	$2.8B-20.6%	$3.6B+19.1%	$3.0B-24.2%	$3.9B+22.2%	$3.2B+11.1%	$2.9B+24.6%	$2.3B+13.3%	$2.1B-6.5%	$2.2B+9.2%	$2.0B+93.8%	$1.0B+9.4%	$951.0M-5.7%	$1.0B-43.7%	$1.8B-40.8%	$3.0B
Non-Current Liabilities	$5.7B+14.3%	$5.0B-8.4%	$5.4B+14.2%	$4.8B-16.1%	$5.7B-0.8%	$5.7B+58.3%	$3.6B+6.4%	$3.4B-0.4%	$3.4B-14.1%	$4.0B+215.5%	$1.3B-5.3%	$1.3B-14.5%	$1.6B+6.3%	$1.5B+0.3%	$1.5B
Long-Term Debt	$4.6B+14.2%	$4.1B-13.1%	$4.7B+18.7%	$3.9B-14.5%	$4.6B-1.1%	$4.6B+58.8%	$2.9B-1.8%	$3.0B-2.5%	$3.1B-5.2%	$3.2B+198.9%	$1.1B-7.3%	$1.2B-12.5%	$1.3B+2.8%	$1.3B-0.3%	$1.3B
Total Equity	$4.9B+11.4%	$4.4B+5.0%	$4.2B-2.3%	$4.3B+0.2%	$4.3B+11.1%	$3.9B+13.2%	$3.4B+3.2%	$3.3B-1.8%	$3.4B+7.5%	$3.1B+193.5%	$1.1B+7.0%	$998.0M-37.4%	$1.6B-39.1%	$2.6B+20.0%	$2.2B
Retained Earnings	$4.6B+36.3%	$3.4B+44.2%	$2.4B-0.1%	$2.4B+25.9%	$1.9B+41.6%	$1.3B+48.2%	$896.0M+113.3%	$420.0M+2900.0%	-$15.0M+91.5%	-$177.0M+36.1%	-$277.0M+34.7%	-$424.0M-1796.0%	$25.0M-95.1%	$510.0M+211.0%	$164.0M

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Total Assets	$15.6B+15.4%	$15.4B+16.6%	$13.5B+3.7%	$13.5B+1.5%	$13.5B+5.0%	$13.2B+3.0%	$13.0B+2.5%	$13.3B+4.6%
Current Assets	$5.2B+9.7%	$4.4B-3.2%	$4.8B+11.1%	$4.8B+3.9%	$4.8B+13.1%	$4.5B+9.6%	$4.3B+8.2%	$4.7B+16.9%
Cash & Equivalents	$748.0M-19.6%	$457.0M-45.7%	$1.1B+30.5%	$974.0M-11.2%	$930.0M+25.0%	$842.0M+53.9%	$849.0M+32.4%	$1.1B+46.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$94.0M-74.2%	$336.0M-3.2%	$342.0M+8.6%	$360.0M+11.5%	$364.0M+9.3%	$347.0M+9.1%	$315.0M+1.6%	$323.0M+9.5%
Accounts Receivable	N/A	N/A	$2.7B+2.4%	N/A	N/A	N/A	$2.6B+8.9%	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$7.7B+20.5%	$8.1B+32.7%	$6.3B+4.2%	$6.3B+3.6%	$6.4B+4.2%	$6.1B0.0%	$6.1B-0.5%	$6.1B+0.7%
Total Liabilities	$10.3B+16.4%	$10.3B+16.1%	$8.5B-0.2%	$8.6B-1.0%	$8.8B+5.3%	$8.9B+4.6%	$8.6B+1.3%	$8.7B+1.4%
Current Liabilities	$3.2B+9.2%	$3.2B+6.5%	$2.8B-20.6%	$3.0B-21.0%	$2.9B-15.9%	$3.0B-4.0%	$3.6B+19.1%	$3.8B+24.4%
Non-Current Liabilities	$7.1B+20.1%	$7.2B+20.8%	$5.7B+14.3%	$5.6B+14.6%	$5.9B+20.4%	$5.9B+9.5%	$5.0B-8.4%	$4.9B-11.3%
Long-Term Debt	$6.0B+20.5%	$6.0B+19.9%	$4.6B+14.2%	$4.6B+13.5%	$5.0B+21.3%	$5.0B+8.2%	$4.1B-13.1%	$4.1B-12.6%
Total Equity	$5.3B+13.3%	$5.0B+17.8%	$4.9B+11.4%	$4.9B+6.4%	$4.7B+4.6%	$4.3B0.0%	$4.4B+5.0%	$4.6B+11.3%
Retained Earnings	$5.2B+28.5%	$4.9B+32.2%	$4.6B+36.3%	$4.4B+37.6%	$4.1B+41.7%	$3.7B+43.4%	$3.4B+44.2%	$3.2B+45.4%

LDOS Cash Flow Statement

LDOS quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$2.3B	$1.8B+22.0%	$1.4B+20.9%	$1.2B+19.7%	$992.0M-4.0%	$1.0B-22.6%	$1.3B+34.5%	$992.0M+29.2%	$768.0M+46.0%	$526.0M+17.1%	$449.0M+17.5%	$382.0M-0.8%	$385.0M+101.6%	$191.0M+695.8%	$24.0M-96.9%	$772.0M
Depreciation & Amortization	N/A	$290.0M0.0%	$290.0M-12.4%	$331.0M-0.6%	$333.0M+2.5%	$325.0M+15.2%	$282.0M+20.5%	$234.0M-8.9%	$257.0M-23.5%	$336.0M+175.4%	$122.0M+197.6%	$41.0M-33.9%	$62.0M-22.5%	$80.0M-11.1%	$90.0M+2.3%	$88.0M
Stock-Based Compensation	N/A	$95.0M+11.8%	$85.0M+10.4%	$77.0M+5.5%	$73.0M+9.0%	$67.0M+8.1%	$62.0M+19.2%	$52.0M+18.2%	$44.0M+2.3%	$43.0M+22.9%	$35.0M+16.7%	$30.0M-28.6%	$42.0M-23.6%	$55.0M+3.8%	$53.0M-3.6%	$55.0M
Capital Expenditures	$137.0M	$125.0M-16.1%	$149.0M-28.0%	$207.0M+60.5%	$129.0M+24.0%	$104.0M-43.2%	$183.0M+51.2%	$121.0M+65.8%	$73.0M-9.9%	$81.0M+179.3%	$29.0M+7.4%	$27.0M-6.9%	$29.0M-45.3%	$53.0M+35.9%	$39.0M-30.4%	$56.0M
Free Cash Flow	$2.2B	$1.6B+26.4%	$1.3B+31.2%	$980.0M+13.6%	$863.0M-7.1%	$929.0M-19.3%	$1.2B+32.1%	$871.0M+25.3%	$695.0M+56.2%	$445.0M+6.0%	$420.0M+18.3%	$355.0M-0.3%	$356.0M+158.0%	$138.0M+1020.0%	-$15.0M-102.1%	$716.0M
Investing Cash Flow	-$2.5B	-$405.0M-185.2%	-$142.0M+32.7%	-$211.0M+32.6%	-$313.0M+57.1%	-$730.0M+74.1%	-$2.8B-4430.8%	$65.0M+157.0%	-$114.0M-60.6%	-$71.0M	N/A	N/A	N/A	N/A	N/A	-$203.0M
Financing Cash Flow	$18.0M	-$1.1B-5.6%	-$1.1B-51.6%	-$715.0M+17.3%	-$865.0M-665.5%	-$113.0M-107.8%	$1.5B+304.7%	-$709.0M-0.3%	-$707.0M-64.8%	-$429.0M	N/A	N/A	N/A	N/A	N/A	-$449.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$993.0M	$0	$0-100.0%	$477.0M+189.1%	$165.0M	$0
Share Buybacks	$666.0M	$400.0M-52.9%	$850.0M+277.8%	$225.0M	$0-100.0%	$237.0M+253.7%	$67.0M+168.0%	$25.0M-85.0%	$167.0M	$0	$0-100.0%	$118.0M-45.1%	$215.0M-32.6%	$319.0M+1350.0%	$22.0M-95.3%	$471.0M

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Operating Cash Flow	$793.0M+63.2%	$301.0M+419.0%	$495.0M+68.4%	$711.0M+9.9%	$486.0M+27.6%	$58.0M-48.7%	$294.0M-9.8%	$647.0M-18.6%
Depreciation & Amortization	$81.0M+12.5%	$72.0M+4.3%	$75.0M-5.1%	$74.0M+4.2%	$72.0M+1.4%	$69.0M0.0%	$79.0M-4.8%	$71.0M-13.4%
Stock-Based Compensation	N/A	$25.0M+19.0%	N/A	N/A	N/A	$21.0M+5.0%	N/A	N/A
Capital Expenditures	$32.0M+10.3%	$31.0M+40.9%	$43.0M-50.0%	$31.0M+34.8%	$29.0M+26.1%	$22.0M+29.4%	$86.0M+10.3%	$23.0M-54.0%
Free Cash Flow	$761.0M+66.5%	$270.0M+650.0%	$452.0M+117.3%	$680.0M+9.0%	$457.0M+27.7%	$36.0M-62.5%	$208.0M-16.1%	$624.0M-16.2%
Investing Cash Flow	-$38.0M+87.9%	-$2.4B-10622.7%	-$33.0M+61.6%	-$36.0M-56.5%	-$314.0M-1395.2%	-$22.0M-83.3%	-$86.0M-13.2%	-$23.0M+55.8%
Financing Cash Flow	-$423.0M-409.6%	$1.4B+1366.4%	-$357.0M+18.9%	-$595.0M-131.5%	-$83.0M+47.8%	-$110.0M+51.8%	-$440.0M-79.6%	-$257.0M-3.2%
Share Buybacks	$66.0M	$200.0M	$300.0M-25.0%	$100.0M-50.0%	$0-100.0%	$0-100.0%	$400.0M+100.0%	$200.0M

Not reported in any period shown, so not listed: Dividends Paid.

LDOS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LDOS quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	18.0%+1.3pp	16.8%+2.2pp	14.5%+0.1pp	14.5%-0.2pp	14.7%+0.5pp	14.1%+0.2pp	14.0%-0.8pp	14.8%+0.7pp	14.1%+0.7pp	13.4%+1.3pp	12.0%-1.2pp	13.3%0.0pp	13.3%-0.7pp	14.0%+5.7pp	8.3%
Operating Margin	12.3%+1.3pp	11.0%+7.0pp	4.0%-3.5pp	7.6%-0.8pp	8.4%+0.3pp	8.1%-0.1pp	8.2%+0.9pp	7.3%+1.8pp	5.5%-0.4pp	5.9%-0.9pp	6.8%+11.0pp	-4.2%-7.1pp	2.8%-3.7pp	6.5%+7.5pp	-1.0%
Net Margin	8.4%+0.9pp	7.5%+6.2pp	1.3%-3.5pp	4.8%-0.7pp	5.5%+0.4pp	5.1%-0.9pp	6.0%+0.3pp	5.7%+2.1pp	3.6%+0.1pp	3.5%-1.7pp	5.1%+11.7pp	-6.6%-9.4pp	2.9%-5.3pp	8.1%+7.1pp	1.0%
Return on Equity	29.4%+1.0pp	28.4%+23.7pp	4.7%-11.2pp	15.9%-1.6pp	17.5%+1.3pp	16.3%-3.3pp	19.5%+2.0pp	17.6%+6.7pp	10.9%+3.1pp	7.8%-14.9pp	22.7%+56.1pp	-33.5%-43.8pp	10.3%-9.8pp	20.1%+17.3pp	2.7%
Return on Assets	10.7%+1.1pp	9.6%+8.1pp	1.6%-3.7pp	5.2%-0.4pp	5.7%+0.7pp	5.0%-2.1pp	7.1%+0.5pp	6.6%+2.5pp	4.1%+1.4pp	2.7%-4.5pp	7.2%+17.4pp	-10.2%-14.1pp	3.9%-5.0pp	8.9%+8.1pp	0.9%
Current Ratio	1.70+0.5x	1.22-0.1x	1.34+0.4x	0.92-0.2x	1.120.0x	1.15-0.1x	1.21-0.2x	1.38+0.2x	1.210.0x	1.18-0.5x	1.720.0x	1.70-0.1x	1.79-0.2x	2.02+0.6x	1.40
Debt-to-Equity	0.940.0x	0.92-0.2x	1.11+0.2x	0.91-0.2x	1.07-0.1x	1.20+0.3x	0.860.0x	0.900.0x	0.91-0.1x	1.030.0x	1.01-0.2x	1.17+0.3x	0.83+0.3x	0.49-0.1x	0.60
Asset Turnover	1.270.0x	1.28+0.1x	1.22+0.1x	1.10+0.1x	1.04+0.1x	0.98-0.2x	1.180.0x	1.160.0x	1.13+0.4x	0.77-0.6x	1.40-0.1x	1.54+0.2x	1.38+0.3x	1.10+0.2x	0.88
FCF Margin	9.5%+1.7pp	7.7%+1.4pp	6.3%+0.4pp	6.0%-0.8pp	6.8%-2.6pp	9.4%+1.5pp	7.8%+1.0pp	6.8%+2.4pp	4.4%-1.6pp	6.0%-1.6pp	7.5%+0.5pp	7.0%+4.6pp	2.4%+2.6pp	-0.2%-12.5pp	12.3%

Metric	Q2'2710-Q	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q
Gross Margin	17.9%-0.5pp	17.3%-0.5pp	17.6%+1.7pp	18.4%+0.2pp	18.4%+1.3pp	17.8%+1.8pp	15.9%+0.9pp	18.2%+3.2pp
Operating Margin	11.3%-2.2pp	11.6%-0.9pp	11.2%+1.6pp	12.0%-0.4pp	13.4%+1.9pp	12.5%+2.0pp	9.6%+0.6pp	12.3%+20.9pp
Net Margin	7.8%-1.4pp	7.4%-1.1pp	7.8%+1.3pp	8.2%-0.5pp	9.2%+1.4pp	8.6%+1.4pp	6.5%+0.8pp	8.7%+18.9pp
Return on Equity	6.7%-1.7pp	6.5%-2.0pp	6.7%+0.2pp	7.5%-0.4pp	8.4%+1.2pp	8.5%+1.9pp	6.4%+1.0pp	7.9%+17.5pp
Return on Assets	2.3%-0.6pp	2.1%-0.6pp	2.4%+0.2pp	2.7%0.0pp	2.9%+0.4pp	2.8%+0.5pp	2.2%+0.4pp	2.7%+5.9pp
Current Ratio	1.630.0x	1.40-0.1x	1.70+0.5x	1.62+0.4x	1.62+0.4x	1.54+0.2x	1.22-0.1x	1.23-0.1x
Debt-to-Equity	1.14+0.1x	1.200.0x	0.940.0x	0.94+0.1x	1.07+0.1x	1.18+0.1x	0.92-0.2x	0.88-0.2x
Asset Turnover	0.290.0x	0.290.0x	0.310.0x	0.330.0x	0.310.0x	0.320.0x	0.340.0x	0.310.0x
FCF Margin	16.7%+6.0pp	6.1%+5.3pp	10.7%+6.0pp	15.2%+0.3pp	10.8%+2.1pp	0.9%-1.6pp	4.8%-1.5pp	14.9%-4.1pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Leidos Holdings, Inc. LDOS	FY2025	$17.2B	$1.4B	8.4%	$16.2B	58/100
CDW Corp CDW	FY2025	$22.4B	$1.1B	4.8%	$17.8B	51/100
Broadridge Finl Solutions Inc BR	FY2026	$7.5B	$1.1B	15.0%	$19.2B	62/100
Wipro WIT	FY2026	$9.9B	$1.4B	14.3%	$16.6B	41/100
Cognizant Technology Solutions CTSH	FY2025	$21.1B	$2.2B	10.6%	$26.2B	74/100

Where Leidos Holdings, Inc. Ranks

Frequently Asked Questions

What is Leidos Holdings, Inc.'s annual revenue?

Leidos Holdings, Inc. (LDOS) reported $17.2B in total revenue for fiscal year 2025. This represents a 3.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Leidos Holdings, Inc.'s revenue growing?

Leidos Holdings, Inc. (LDOS) revenue grew by 3.1% year-over-year, from $16.7B to $17.2B in fiscal year 2025.

Is Leidos Holdings, Inc. profitable?

Yes, Leidos Holdings, Inc. (LDOS) reported a net income of $1.4B in fiscal year 2025, with a net profit margin of 8.4%.

What is Leidos Holdings, Inc.'s EBITDA?

Leidos Holdings, Inc. (LDOS) had EBITDA of $2.4B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Leidos Holdings, Inc. have?

As of fiscal year 2025, Leidos Holdings, Inc. (LDOS) had $1.1B in cash and equivalents against $4.6B in long-term debt.

What is Leidos Holdings, Inc.'s gross margin?

Leidos Holdings, Inc. (LDOS) had a gross margin of 18.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Leidos Holdings, Inc.'s operating margin?

Leidos Holdings, Inc. (LDOS) had an operating margin of 12.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Leidos Holdings, Inc.'s net profit margin?

Leidos Holdings, Inc. (LDOS) had a net profit margin of 8.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Leidos Holdings, Inc. pay dividends?

Yes, Leidos Holdings, Inc. (LDOS) paid $1.63 per share in dividends during fiscal year 2025.

What is Leidos Holdings, Inc.'s return on equity (ROE)?

Leidos Holdings, Inc. (LDOS) has a return on equity of 29.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Leidos Holdings, Inc.'s free cash flow?

Leidos Holdings, Inc. (LDOS) generated $1.6B in free cash flow during fiscal year 2025. This represents a 26.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Leidos Holdings, Inc.'s operating cash flow?

Leidos Holdings, Inc. (LDOS) generated $1.8B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Leidos Holdings, Inc.'s total assets?

Leidos Holdings, Inc. (LDOS) had $13.5B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Leidos Holdings, Inc.'s capital expenditures?

Leidos Holdings, Inc. (LDOS) invested $125.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Leidos Holdings, Inc. spend on research and development?

Leidos Holdings, Inc. (LDOS) invested $187.0M in research and development during fiscal year 2025.

Does Leidos Holdings, Inc. buy back shares?

Yes, Leidos Holdings, Inc. (LDOS) spent $400.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Leidos Holdings, Inc. have outstanding?

Leidos Holdings, Inc. (LDOS) had 126M shares outstanding as of fiscal year 2025.

What is Leidos Holdings, Inc.'s current ratio?

Leidos Holdings, Inc. (LDOS) had a current ratio of 1.70 as of fiscal year 2025, which is generally considered healthy.

What is Leidos Holdings, Inc.'s debt-to-equity ratio?

Leidos Holdings, Inc. (LDOS) had a debt-to-equity ratio of 0.94 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Leidos Holdings, Inc.'s return on assets (ROA)?

Leidos Holdings, Inc. (LDOS) had a return on assets of 10.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Leidos Holdings, Inc.'s P/E ratio?

Leidos Holdings, Inc. (LDOS) trades at 11.8x earnings, its market capitalization divided by net income of $1.4B net income, trailing 12 months to July 3, 2026. The market capitalization is $16.2B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Leidos Holdings, Inc.'s price-to-sales ratio?

Leidos Holdings, Inc. (LDOS) trades at 0.9x sales, its market capitalization divided by revenue of $17.6B revenue, trailing 12 months to July 3, 2026. The market capitalization is $16.2B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Leidos Holdings, Inc.'s Altman Z-Score?

Leidos Holdings, Inc. (LDOS) has an Altman Z-Score of 3.58, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Leidos Holdings, Inc.'s Piotroski F-Score?

Leidos Holdings, Inc. (LDOS) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Leidos Holdings, Inc.'s earnings high quality?

Leidos Holdings, Inc. (LDOS) has an earnings quality ratio of 1.21x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Leidos Holdings, Inc. cover its interest payments?

Leidos Holdings, Inc. (LDOS) has an interest coverage ratio of 10.39x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Leidos Holdings, Inc.?

Leidos Holdings, Inc. (LDOS) scores 58 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.